[1] |
.
Consensus on the diagnosis and therapy of hepatic fibrosis
[J]. Journal of Practical Hepatology, 2019, 22(6): 793-803.
|
[2] |
Min Feng, Huang Wenqi, Wu Weibing, et al..
Implications of serum adipocytokine levels in patients with chronic hepatitis B
[J]. Journal of Practical Hepatology, 2019, 22(6): 824-827.
|
[3] |
Chen Meimei, Duan Xiaoyan, Cao Haixia, et al..
Improvement of clinical symptoms and serum hepatic fibrosis markers in patients with primary biliary cirrhosis by compound Biejiaruangan tablets
[J]. Journal of Practical Hepatology, 2019, 22(6): 880-883.
|
[4] |
Wu Yaping, Zhou Bingqing, Jiang Peili.
Risk factors of severe hepatic fibrosis in patients with chronic hepatitis C with previous paid blood donation
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 196-199.
|
[5] |
Liu Enqiang, Chen Guo, Liao Xiuyong, et al..
Inhibition of TGF-β1/Smad/ERK passway by astaxanthin in rats with CCl4-induced liver fibrosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 842-846.
|
[6] |
Pan Gaofeng, Fu Maoying, Gao Yufeng..
Endoplasmic reticulum stress in pathogenesis of hepatic fibrosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(6): 987-990.
|
[7] |
Zhu Chuanlong,Zhu Tiantian,Wang Kung,et al..
Serum Pygo2 levels as an indicator of liver fibrosis in patients with chronic hepatitis C
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(2): 161-164.
|
[8] |
Hu Ye, Zhang Guo..
Diagnosis, severity assessment of hepatic fibrosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(1): 13-16.
|
[9] |
Zhang Jianqiong,Xu Liang,Li Ping,et al..
Diagnostic efficacy of FibroScan and three diagnostic models in diagnosis of liver fibrosis in chronic hepatitis B patients with mild hepatic steatosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(6): 663-668.
|
[10] |
Cai Lebin, Tao Na..
Efficacy of pegylated interferon α-2a combined with adefovir dipivoxil and their effects on serum T lymphocyte cytokines and hepatic fibrosis indexes in patients with HBeAg-positive chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 532-535.
|
[11] |
Qian Peiguo, Lian Xiaoxiao, Guo Xiaoxia..
Application of noninvasive diagnostic model in diagnosis of liver fibrosis in patients with hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(5): 578-582.
|
[12] |
Tong Yanyan, Li Guangming, Deng Yilin, et al.
Inhibition of primary cultured hepatic stellate cell activation by phenylarsine oxide in vitro
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(4): 413-417.
|
[13] |
Lu Lungen.
Highlight in hepatic fibrosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 1-3.
|
[14] |
Zhao Yuqian, Xu Xingmei, Yang Huijuan, et al.
Clinical observation of entecavir combined with Liuweiwuling tablets in treatment of patients with chronic hepatitis B
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2016, 19(1): 83-85.
|
[15] |
Huang Hong,Kang Yi,Huang Xuping,et al..
Effect of malotilate on expression of Smads protein in rats with dimenthylnitrosamine-induced hepatic fibrosis
[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(5): 525-529.
|